9-beta-D-Arabinofuranosyladenine, 99%
9-beta-D-Arabinofuranosyladenine, 99%
9-beta-D-Arabinofuranosyladenine, 99%
Thermo Scientific Chemicals

9-beta-D-Arabinofuranosyladenine, 99%

CAS: 5536-17-4 | C10H13N5O4 | 267.25 g/mol
製品番号(カタログ番号) J65076.06
または、製品番号J65076-06
価格(JPY)
-
数量:
5 g
一括またはカスタム形式をリクエストする
仕様
バイルシュタイン624881
CAS5536-17-4
化学物質名または材質9-beta-D-Arabinofuranosyladenine
White
EINECS番号226-893-9
さらに表示
Vidarabine is a neurotransmitter that acts as the preferred endogenous agonist at all adenosine receptor subtypes. Vidarabine is an inhibitor of A cyclase and DNA Polymerase. Used to study the roles of AMP-activated protein kinase (AMPK) in cell signaling. Cell-permeable adenylate cyclase inhibitor; in detergent-dispersed rat brain preparation, IC50 = 30 ?M. Clinically significant antiviral agent, especially against herpes simplex (HSV),1 by inhibition of DNA polymerase.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Vidarabine is a neurotransmitter that acts as the preferred endogenous agonist at all adenosine receptor subtypes. Vidarabine is an inhibitor of A cyclase and DNA Polymerase. Used to study the roles of AMP-activated protein kinase (AMPK) in cell signaling. Cell-permeable adenylate cyclase inhibitor; in detergent-dispersed rat brain preparation, IC50 = 30 μM. Clinically significant antiviral agent, especially against herpes simplex (HSV),1 by inhibition of DNA polymerase.

Solubility
Soluble in DMF (10 mg/ml), 0.5 M HCl (50 mg/ml), DMSO (53 mg/ml at 25°C), ethanol (<1mg/mL at 25°C), and water (3 mg/ml at 25°C).

Notes
Keep container tightly closed. Store away from oxidizing agents.
RUO – Research Use Only

General References:

  1. Gene D. Morse.; Mark J. Shelton.; Alice M. O Donnell. Comparative Pharmacokinetics of Antiviral Nucleoside Analogues. Clinical Pharmacokinetics. 1993, 24, (2), 101-123.
  2. John A. SecristIII.; Anita T. Shortnacy.; John A. Montgomery. Synthesis and biological evaluations of certain 2-halo-2'-substituted derivatives of 9-.beta.-D-arabinofuranosyladenine. J. Med. Chem. 1988, 31, (2), 405-410.